▲ | Manuel_D 6 days ago | |||||||
> I don't think patients who want to be addressed as a women particularly wish to end up 6'4" tall with broad shoulders, but those are unintended side effects of unwanted puberty for a significant number of people currently requesting blockers. For the third time your claim was that puberty blockers are reversible. This is false. If this hypothetical child decided to stop taking puberty blockers, the impact on height would not be reversed. He would not reach the same height if he took blockers and stopped than if he never took blockers at all. Puberty blockers are not reversible. And again, impacts on bone density and inability to achieve orgasm are most certainly not desired and these side effects go entirely unmentioned in your response. I don't know why you imply there's no research on these side effects: https://pmc.ncbi.nlm.nih.gov/articles/PMC9578106/#:~:text=Re.... > Results consistently indicate a negative impact of long-term puberty suppression on bone mineral density, especially at the lumbar spine, which is only partially restored after sex steroid administration. Trans girls are more vulnerable than trans boys for compromised bone health. https://pmc.ncbi.nlm.nih.gov/articles/PMC9886596/#:~:text=Pu.... > Puberty blockers, cross-sex hormones and genital surgery also pose risks to sexual function, particularly the physiological capacity for arousal and orgasm. It is important to be aware there is a dearth of research studying the impact of GAT on GD youth’s sexual function, but I provide a brief discussion of this important topic. Estrogen use in transwomen is associated with decreased sexual desire and erectile dysfunction and testosterone for transmen may lead to vaginal atrophy and dyspareunia | ||||||||
▲ | notahacker 6 days ago | parent [-] | |||||||
I'm not sure why you think that bringing up a survey showing moderately reduced bone density following long term puberty suppression and transition (sonething actually referenced by Scientific American, along with a note the cause/effect wasn't settled given that gender dysphoria sufferers also tend to have smaller bone structure than average before starting treatment, plausibly due due exercise effects) is evidence of "brittle bones that break more often" being a significant risk factor, which is your actual claim. For the third time, my point is that the Cass Report concluded that the evidence base that found the treatment safe and regret rates low didn't meet the highest possible bar for quality and coverage, and did not offer supporting evidence of the greater merit of claims made to promote the idea that puberty blockers were unsafe when used for gender dysphoria, relative to other treatments or other use of the same treatment, such as wild insinuations about bone-breaking being a common side effect of their temporary use... For similar reasons, studies which shows erectile dysfunction is not uncommon in patients who have chosen to continue treatment using oestrogen, (universally agreed to have irreversible consequences; it's literally the point of using puberty blockers rather than going straight to sex hormones) is not a high standard of evidence that using puberty blockers for a few months aged 11 is significantly less reversible than using for a year or two aged nine. The actual claim being made: that the treatment is reversible in the sense that children are able to come off it and go through puberty, isn't really being contested here either. | ||||||||
|